|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of Pittsburgh |
| Information provided by: | University of Pittsburgh |
| ClinicalTrials.gov Identifier: | NCT00295087 |
Purpose
Women who are affected with premature ovarian failure will exhibit skewed X-chromosome inactivation patterns compared to women with normal menstrual function (as defined by being pregnant), indicating a possible X-chromosome defect.
| Condition |
|
Premature Ovarian Failure |
| MedlinePlus related topics: | Premature Ovarian Failure |
| Study Type: | Observational |
| Study Design: | Cohort, Cross-Sectional |
| Official Title: | X-Chromosome Inactivation Status and Premature Ovarian Failure |
DNA that is extarcted from the blood specimen
| Estimated Enrollment: | 40 |
| Study Start Date: | November 2005 |
| Estimated Study Completion Date: | November 2008 |
| Estimated Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Premature ovarian failure (POF) affects approximately 1% of women. For most women a cause is not found, but structural abnormalities of the X-chromosome commonly lead to POF, suggesting genes on the X-chromosome are necessary for normal ovarian function. It is known that certain gene mutations on the X-chromosome can lead to changes in the normal random pattern of X-chromosome inactivation in females.
We propose to study X-inactivation patterns in a cohort of women with idiopathic POF, and compare their pattern to a mean age-matched cohort of women with normal menstrual function.
We hypothesize that some women with POF will show skewed X-inactivation, suggesting a mutation on the X-chromosome as the etiology of their POF.
Eligibility
| Ages Eligible for Study: | 20 Years to 40 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study population will include women diagnosed with POF through clinics. Women diagnosed with POF may also inquire about this study through the Clinical Trials website.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Heather A Huber, BS | 412-641-6063 | rsihah@mwri.magee.edu |
| United States, Pennsylvania | |||||
| Magee-Womens Hospital | Recruiting | ||||
| Pittsburgh, Pennsylvania, United States, 15213 | |||||
| Contact: Heather A Huber, BS 412-641-6063 rsihah@mwri.magee.edu | |||||
| Contact: W. Allen Hogge, MD 412-641-4212 whogge@mail.magee.edu | |||||
| Principal Investigator: W. Allen Hogge, MD | |||||
| Sub-Investigator: Joseph S Sanfilippo, MD, MBA | |||||
| University of Pittsburgh |
| Principal Investigator: | W. Allen Hogge, MD | University of Pittsburgh and Magee-Womens Hospital |
More Information
| Responsible Party: | University of Pittsburgh/Magee-Womens Hospital ( W. Allen Hogge, MD ) |
| Study ID Numbers: | 0511043 |
| First Received: | February 17, 2006 |
| Last Updated: | August 5, 2008 |
| ClinicalTrials.gov Identifier: | NCT00295087 |
| Health Authority: | United States: Institutional Review Board |
|
|
|
|